Observational studyDiabetes & metabolism journal2022

A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus.

Bo-Yeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.